12
Participants
Start Date
July 5, 2022
Primary Completion Date
May 29, 2023
Study Completion Date
May 29, 2023
Formoterol Fumarate 12 micrograms Inhalation Powder
At time 60 minutes, a total of 48 micrograms will be inhaled within 3 minutes: 4 inhalations of 12 micrograms of fumarate formoterol (Oxeze® Turbuhaler®).
Nicotinic Acid 50 MG Oral Tablet
a total dose of 1050 MG will be ingested. From time 0 to 180 minutes, doses of 150 MG will be repeated every 30 minutes.
Acute Cold Exposure
Participants will be fitted with a liquid-conditioned tube suit. The liquid-conditioned tube suit will be perfused with 18°C water using a temperature- and flow-controlled circulation bath from time 0 to 180 min.
Positron Emission Tomography (PET)
PET imaging using C11-palmitate (time 90), C11-acetate (time 120) and F18-Fluorodeoxyglucose (FDG) (time 150)
Indirect calorimetry
will be repeated every hour, for 20 minutes, using Vmax29n.
dual-energy x-ray absorptiometry (DEXA scan)
Whole body scan
Biopsy
After local anesthesia with 2% xylocaine without epinephrine, 100-200 mg of subcutaneous adipose tissue will be sampled by needle (14G) biopsy
iv lines
for stable tracer perfusion and blood sampling
Electromyogram (EMG)
Surface electrodes will be used to measure skeletal muscle activity and shivering intensity
Centre de recherche du CHUS, Sherbrooke
Université de Sherbrooke
OTHER